American Well Corporation (AMWL)
6.98
-0.04 (-0.57%)
At close: Apr 17, 2025, 3:59 PM
6.89
-1.26%
After-hours: Apr 17, 2025, 08:00 PM EDT
Company Description
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare.
The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings.
Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks.
American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
American Well Corporation
| Country | United States |
| IPO Date | Sep 17, 2020 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 877 |
| CEO | Dr. Ido Schoenberg M.D. |
Contact Details
Address: 75 State Street Boston, Massachusetts United States | |
| Website | https://amwell.com |
Stock Details
| Ticker Symbol | AMWL |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001393584 |
| CUSIP Number | 03044L204 |
| ISIN Number | US03044L2043 |
| Employer ID | 00-0000000 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ido Schoenberg M.D. | Chairman & Chief Executive Officer |
| Mark J. Hirschhorn CPA | Chief Operating Officer & Chief Financial Officer |
| Dan Zamansky | Chief Product & Technology Officer |
| Dr. Roy Schoenberg M.D., M.P.H. | Executive Vice Chairman |
| Paul Francis McNeice | Vice President of Accounting |
| Phyllis I. Gotlib | President of Amwell International |
| Sue Dooley | Head of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 03, 2025 | 4 | Filing |
| Apr 03, 2025 | 4 | Filing |
| Mar 10, 2025 | 4 | Filing |
| Mar 10, 2025 | 3 | Filing |
| Mar 05, 2025 | 4 | Filing |
| Mar 05, 2025 | 4 | Filing |
| Mar 03, 2025 | 8-K | Current Report |
| Feb 28, 2025 | S-8 | Filing |
| Feb 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Feb 12, 2025 | 10-K | Annual Report |